Metabolic & GLP
NNMT Inhibition Studies
Quantity
Ships from the United States with tracking · free shipping over $200
Certificates of analysis
Each certificate covers one production run, and reports on that batch alone. Open any of them to read the laboratory report exactly as the third-party lab issued it.
Authenticity
Scan the code on the label to pull up every published certificate for that compound — the same reports the third-party laboratory issued, batch by batch. Traceable from the laboratory that tested it to your bench.
Verify a batch →Independently tested
Purity is quantified by reverse-phase HPLC and identity confirmed by mass spectrometry, by an outside laboratory rather than in-house.
A certificate for your lot
The report that ships with your order describes the batch you received — not the product line, and not a representative sample.
COA-backed replacement
If material does not match the certificate issued for its lot, we replace it or refund it. Send us the lot number and we will trace it.
Tracked dispatch
Tracking is issued when the label is created, so the shipment is traceable from the moment it leaves us.
About this compound
C10H10N2
Unusually for this catalog, 5-Amino-1MQ is a small molecule and not a peptide at all. It inhibits nicotinamide N-methyltransferase (NNMT), an enzyme that consumes nicotinamide — the precursor cells draw on to build NAD+. Blocking that consumption is the premise behind its use in metabolic research, where studies typically track NAD+ availability and adipocyte behavior rather than the enzyme itself.
Full specification
How it works
The pathways 5-Amino-1MQ acts on, and what each one does. Signalling described from preclinical models.
Nicotinamide N-Methyltransferase Blockade
A competitive small-molecule inhibitor of NNMT — the enzyme that methylates nicotinamide and, in doing so, takes it out of circulation. Blocking that step is the whole premise; nothing else about the compound is unusual.
NAD+ Precursor Salvage Pathway Modulation
With NNMT inhibited, nicotinamide is reported to return to the salvage pathway rather than being consumed, raising the precursor pool available for NAD+ synthesis. The compound does not supply NAD+ — it is described as reducing a drain on it.
Adipose Tissue Energy Expenditure
Diet-induced obese mouse models report reduced white adipose mass following NNMT inhibition. This is the endpoint most cited for the compound, and it remains rodent data.
Uses & applications
The main areas under study, and the study-reported figures behind them.
Diet-induced obese rodent models report reduced white adipose mass following NNMT inhibition. This is the most-cited endpoint for the compound and it remains animal data.
Hong S et al. 2015
The proposed route is indirect: blocking nicotinamide consumption leaves more precursor available for NAD+ synthesis rather than supplying NAD+ directly.
Kannt A et al. 2015
Because NNMT consumes S-adenosylmethionine as its methyl donor, inhibiting it also shifts the methyl-donor pool — which is why the compound appears in epigenetic work at all.
Pissios P. 2017
Insulin sensitivity endpoints are measured alongside the adiposity ones, generally in the same models rather than as an independent line.
Kraus D et al. 2014
What the published work measures
The endpoints reported across the literature for this compound. The figures belong to the individual papers, not to us.
Molecular structure
The deposited three-dimensional conformer for this compound, paired with its verified reference values.
Drag to rotate
23 atoms
23 atoms, 24 bonds, C10H11N2+. Deposited conformer from PubChem CID 950107, not a drawing.
C10H10N2
Third-party verified
Every batch of 5-Amino-1MQ is sent to an accredited independent laboratory before it ships. Here is what we screen for.
Quantifies purity and reports it on the lot certificate
Verifies the exact molecular identity
Lead, arsenic, cadmium & mercury
Bacterial endotoxin levels
No microbial contamination
Actual peptide mass per vial verified
FAQ
Unusually for this catalog, 5-Amino-1MQ is a small molecule and not a peptide at all. It inhibits nicotinamide N-methyltransferase (NNMT), an enzyme that consumes nicotinamide — the precursor cells draw on to build NAD+. Blocking that consumption is the premise behind its use in metabolic research, where studies typically track NAD+ availability and adipocyte behavior rather than the enzyme itself.
Published research on 5-Amino-1MQ concentrates on Obesity & Adiposity, NAD+ Salvage Pathway, SAM Methyl Donor Pool and Glucose Homeostasis. Each of those areas is summarised further up this page with the citation it comes from, and the full reference list — 4 indexed publications — sits at the bottom. Study designs and concentrations vary considerably between publications, so the primary sources are worth reading directly.
The literature describes 5-Amino-1MQ acting across Nicotinamide N-Methyltransferase Blockade, NAD+ Precursor Salvage Pathway Modulation and Adipose Tissue Energy Expenditure, reported respectively as NNMT Inhibition, NAD+ Metabolism and Adipocyte Metabolism. Those pathways are drawn from preclinical models rather than clinical work, and they describe what has been observed rather than a settled mechanism — the individual pathway cards above cite what each one is based on.
5-Amino-1MQ has a molecular formula of C10H10N2 and an average mass of 158.19 g/mol. It is indexed under CAS 4213-45-0. It ships as lyophilized powder. Those are nominal reference values for the parent compound. The identity of the specific material you receive is confirmed by mass spectrometry and reported on that lot's certificate.
Store the sealed vial at -20°C, protect from light, protected from light and moisture, and let it reach room temperature before opening so condensation does not form on cold powder. Keep reconstituted solution refrigerated and avoid repeated freeze-thaw cycles — solutions are far less stable than lyophilized powder.
No. 5-Amino-1MQ is supplied strictly for in-vitro laboratory research and development. It is not a drug, food, supplement or cosmetic, it has not been evaluated by the FDA, and it is not intended for human or animal consumption, ingestion, injection or any in-vivo use. Ordering confirms you are a qualified researcher or institution purchasing on that basis.
Cited sources
Independent published research indexed from PubMed and peer-reviewed journals — not Routine Peptides claims.
For research use only
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
Before you order
Every production run is analyzed by an independent laboratory, and the certificate for your lot travels with the order — not a catalog-wide document, and not a summary written by us.
